Global Irritable Bowel Syndrome Treatment Market Insights, Forecast to 2025

Publisher Name :
Date: 12-Jun-2019
No. of pages: 115
Inquire Before Buying

Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms.

Increased awareness about available treatment among the patients, medical community is one of the major driver in global irritable bowel syndrome treatment market.Increase in the number of patients, rise in the aging population, increasing demand for efficiency, increase in the incidence and prevalence of irritable bowel syndrome cases and increase in awareness, the global irritable bowel syndrome market is expected to have a healthy growth rate in the forecast period.

The global Irritable Bowel Syndrome Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Irritable Bowel Syndrome Treatment market based on company, product type, end user and key regions.

This report studies the global market size of Irritable Bowel Syndrome Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Irritable Bowel Syndrome Treatment in these regions.

This research report categorizes the global Irritable Bowel Syndrome Treatment market by top players/brands, region, type and end user. This report also studies the global Irritable Bowel Syndrome Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Valeant Pharmaceuticals International

- Sucampo Pharmaceuticals

- Abbott Laboratories

- Lexicon Pharmaceuticals

- Salix Pharmaceuticals

- Ironwood Pharmaceuticals

- GlaxoSmithKline

- Allergan

Market size by Product

- Irritable Bowel Syndrome with Constipation

- Irritable Bowel Syndrome with Diarrhea

- Irritable Bowel Syndrome with alternating Constipationand Diarrhea

Market size by End User

- Hospitals

- Clinics

- Homecare settings

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Irritable Bowel Syndrome Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Irritable Bowel Syndrome Treatment market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Irritable Bowel Syndrome Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Irritable Bowel Syndrome Treatment submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Irritable Bowel Syndrome Treatment are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Irritable Bowel Syndrome Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Irritable Bowel Syndrome Treatment Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Irritable Bowel Syndrome Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by Product
1.4.2 Irritable Bowel Syndrome with Constipation
1.4.3 Irritable Bowel Syndrome with Diarrhea
1.4.4 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
1.5 Market by End User
1.5.1 Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Homecare settings
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Irritable Bowel Syndrome Treatment Market Size
2.1.1 Global Irritable Bowel Syndrome Treatment Revenue 2014-2025
2.1.2 Global Irritable Bowel Syndrome Treatment Sales 2014-2025
2.2 Irritable Bowel Syndrome Treatment Growth Rate by Regions
2.2.1 Global Irritable Bowel Syndrome Treatment Sales by Regions
2.2.2 Global Irritable Bowel Syndrome Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Irritable Bowel Syndrome Treatment Sales by Manufacturers
3.1.1 Irritable Bowel Syndrome Treatment Sales by Manufacturers
3.1.2 Irritable Bowel Syndrome Treatment Sales Market Share by Manufacturers
3.1.3 Global Irritable Bowel Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Irritable Bowel Syndrome Treatment Revenue by Manufacturers
3.2.1 Irritable Bowel Syndrome Treatment Revenue by Manufacturers (2014-2019)
3.2.2 Irritable Bowel Syndrome Treatment Revenue Share by Manufacturers (2014-2019)
3.3 Irritable Bowel Syndrome Treatment Price by Manufacturers
3.4 Irritable Bowel Syndrome Treatment Manufacturing Base Distribution, Product Types
3.4.1 Irritable Bowel Syndrome Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Irritable Bowel Syndrome Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Irritable Bowel Syndrome Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Irritable Bowel Syndrome Treatment Sales by Product
4.2 Global Irritable Bowel Syndrome Treatment Revenue by Product
4.3 Irritable Bowel Syndrome Treatment Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Irritable Bowel Syndrome Treatment Breakdown Data by End User
6 North America
6.1 North America Irritable Bowel Syndrome Treatment by Countries
6.1.1 North America Irritable Bowel Syndrome Treatment Sales by Countries
6.1.2 North America Irritable Bowel Syndrome Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Irritable Bowel Syndrome Treatment by Product
6.3 North America Irritable Bowel Syndrome Treatment by End User
7 Europe
7.1 Europe Irritable Bowel Syndrome Treatment by Countries
7.1.1 Europe Irritable Bowel Syndrome Treatment Sales by Countries
7.1.2 Europe Irritable Bowel Syndrome Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Irritable Bowel Syndrome Treatment by Product
7.3 Europe Irritable Bowel Syndrome Treatment by End User
8 Asia Pacific
8.1 Asia Pacific Irritable Bowel Syndrome Treatment by Countries
8.1.1 Asia Pacific Irritable Bowel Syndrome Treatment Sales by Countries
8.1.2 Asia Pacific Irritable Bowel Syndrome Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Irritable Bowel Syndrome Treatment by Product
8.3 Asia Pacific Irritable Bowel Syndrome Treatment by End User
9 Central & South America
9.1 Central & South America Irritable Bowel Syndrome Treatment by Countries
9.1.1 Central & South America Irritable Bowel Syndrome Treatment Sales by Countries
9.1.2 Central & South America Irritable Bowel Syndrome Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Irritable Bowel Syndrome Treatment by Product
9.3 Central & South America Irritable Bowel Syndrome Treatment by End User
10 Middle East and Africa
10.1 Middle East and Africa Irritable Bowel Syndrome Treatment by Countries
10.1.1 Middle East and Africa Irritable Bowel Syndrome Treatment Sales by Countries
10.1.2 Middle East and Africa Irritable Bowel Syndrome Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Irritable Bowel Syndrome Treatment by Product
10.3 Middle East and Africa Irritable Bowel Syndrome Treatment by End User
11 Company Profiles
11.1 Valeant Pharmaceuticals International
11.1.1 Valeant Pharmaceuticals International Company Details
11.1.2 Company Business Overview
11.1.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Valeant Pharmaceuticals International Irritable Bowel Syndrome Treatment Products Offered
11.1.5 Valeant Pharmaceuticals International Recent Development
11.2 Sucampo Pharmaceuticals
11.2.1 Sucampo Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Products Offered
11.2.5 Sucampo Pharmaceuticals Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Company Business Overview
11.3.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Abbott Laboratories Irritable Bowel Syndrome Treatment Products Offered
11.3.5 Abbott Laboratories Recent Development
11.4 Lexicon Pharmaceuticals
11.4.1 Lexicon Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Products Offered
11.4.5 Lexicon Pharmaceuticals Recent Development
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Products Offered
11.5.5 Salix Pharmaceuticals Recent Development
11.6 Ironwood Pharmaceuticals
11.6.1 Ironwood Pharmaceuticals Company Details
11.6.2 Company Business Overview
11.6.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Products Offered
11.6.5 Ironwood Pharmaceuticals Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 Company Business Overview
11.7.3 GlaxoSmithKline Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
11.7.4 GlaxoSmithKline Irritable Bowel Syndrome Treatment Products Offered
11.7.5 GlaxoSmithKline Recent Development
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Company Business Overview
11.8.3 Allergan Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Allergan Irritable Bowel Syndrome Treatment Products Offered
11.8.5 Allergan Recent Development
12 Future Forecast
12.1 Irritable Bowel Syndrome Treatment Market Forecast by Regions
12.1.1 Global Irritable Bowel Syndrome Treatment Sales Forecast by Regions 2019-2025
12.1.2 Global Irritable Bowel Syndrome Treatment Revenue Forecast by Regions 2019-2025
12.2 Irritable Bowel Syndrome Treatment Market Forecast by Product
12.2.1 Global Irritable Bowel Syndrome Treatment Sales Forecast by Product 2019-2025
12.2.2 Global Irritable Bowel Syndrome Treatment Revenue Forecast by Product 2019-2025
12.3 Irritable Bowel Syndrome Treatment Market Forecast by End User
12.4 North America Irritable Bowel Syndrome Treatment Forecast
12.5 Europe Irritable Bowel Syndrome Treatment Forecast
12.6 Asia Pacific Irritable Bowel Syndrome Treatment Forecast
12.7 Central & South America Irritable Bowel Syndrome Treatment Forecast
12.8 Middle East and Africa Irritable Bowel Syndrome Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Irritable Bowel Syndrome Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Irritable Bowel Syndrome Treatment Product Picture
Table Irritable Bowel Syndrome Treatment Market Segments
Table Key Manufacturers Irritable Bowel Syndrome Treatment Covered
Table Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share by Product 2014-2025
Figure Irritable Bowel Syndrome with Constipation Product Picture
Table Major Manufacturers of Irritable Bowel Syndrome with Constipation
Figure Irritable Bowel Syndrome with Diarrhea Product Picture
Table Major Manufacturers of Irritable Bowel Syndrome with Diarrhea
Figure Irritable Bowel Syndrome with alternating Constipationand Diarrhea Product Picture
Table Major Manufacturers of Irritable Bowel Syndrome with alternating Constipationand Diarrhea
Table Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by End User 2019-2025 (MT)
Figure Hospitals
Figure Clinics
Figure Homecare settings
Figure Irritable Bowel Syndrome Treatment Report Years Considered
Figure Global Irritable Bowel Syndrome Treatment Market Size 2014-2025 (Million US$)
Figure Global Irritable Bowel Syndrome Treatment Sales 2014-2025 (MT)
Table Global Irritable Bowel Syndrome Treatment Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Irritable Bowel Syndrome Treatment Sales by Regions 2014-2019 (MT)
Table Global Irritable Bowel Syndrome Treatment Sales Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share by Regions 2014-2019
Figure 2018 Global Irritable Bowel Syndrome Treatment Sales Market Share by Regions
Table Global Irritable Bowel Syndrome Treatment Revenue by Regions 2014-2019 (Million US$)
Table Global Irritable Bowel Syndrome Treatment Revenue Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome Treatment Revenue Market Share by Regions 2014-2019
Figure 2018 Global Irritable Bowel Syndrome Treatment Revenue Market Share by Regions
Table Global Irritable Bowel Syndrome Treatment Sales by Manufacturers (2014-2019) (MT)
Table Global Irritable Bowel Syndrome Treatment Sales Share by Manufacturers (2014-2019)
Figure Global Irritable Bowel Syndrome Treatment Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Irritable Bowel Syndrome Treatment Revenue by Manufacturers (2014-2019) (Million USD)
Table Irritable Bowel Syndrome Treatment Revenue Share by Manufacturers (2014-2019)
Figure Irritable Bowel Syndrome Treatment Value Share by Manufacturers in 2018
Table Key Manufacturers Irritable Bowel Syndrome Treatment Price (2014-2019) (USD/Kg)
Table Irritable Bowel Syndrome Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Irritable Bowel Syndrome Treatment Product Type
Table Date of International Manufacturers Enter into Irritable Bowel Syndrome Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Irritable Bowel Syndrome Treatment Sales by Product (2014-2019) (MT)
Table Global Irritable Bowel Syndrome Treatment Sales Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome Treatment Sales Market Share by Product in 2018
Table Global Irritable Bowel Syndrome Treatment Revenue by Product (2014-2019) (Million US$)
Table Global Irritable Bowel Syndrome Treatment Revenue Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome Treatment Revenue Market Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome Treatment Revenue Market Share by Product in 2018
Table Irritable Bowel Syndrome Treatment Price by Product 2014-2019 (USD/Kg)
Table Global Irritable Bowel Syndrome Treatment Sales by End User (2014-2019) (MT)
Table Global Irritable Bowel Syndrome Treatment Sales Share by End User (2014-2019)
Figure Global Sales Irritable Bowel Syndrome Treatment Market Share by End User (2014-2019)
Figure Global Sales Irritable Bowel Syndrome Treatment Market Share by End User in 2018
Figure North America Irritable Bowel Syndrome Treatment Sales Growth Rate 2014-2019 (MT)
Figure North America Irritable Bowel Syndrome Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table North America Irritable Bowel Syndrome Treatment Sales by Countries (2014-2019) (MT)
Table North America Irritable Bowel Syndrome Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome Treatment Sales Market Share by Countries
Table North America Irritable Bowel Syndrome Treatment Revenue by Countries (2014-2019) (Million US$)
Table North America Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome Treatment Revenue Market Share by Countries
Figure United States Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure United States Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (MT)
Figure Canada Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Canada Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Mexico Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table North America Irritable Bowel Syndrome Treatment Sales by Product (2014-2019) (MT)
Table North America Irritable Bowel Syndrome Treatment Sales Market Share by Product (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome Treatment Market Share by Product
Table North America Irritable Bowel Syndrome Treatment Sales by End User (2014-2019) (MT)
Table North America Irritable Bowel Syndrome Treatment Sales Market Share by End User (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome Treatment Market Share by End User
Figure Europe Irritable Bowel Syndrome Treatment Sales Growth Rate 2014-2019 (MT)
Figure Europe Irritable Bowel Syndrome Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Irritable Bowel Syndrome Treatment Sales by Countries (2014-2019) (MT)
Table Europe Irritable Bowel Syndrome Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome Treatment Sales Market Share by Countries
Table Europe Irritable Bowel Syndrome Treatment Revenue by Countries (2014-2019) (Million US$)
Table Europe Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome Treatment Revenue Market Share by Countries
Figure Germany Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Germany Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure France Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure France Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure UK Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Italy Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Russia Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Irritable Bowel Syndrome Treatment Sales by Product (2014-2019) (MT)
Table Europe Irritable Bowel Syndrome Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome Treatment Market Share by Product
Table Europe Irritable Bowel Syndrome Treatment Sales by End User (2014-2019) (MT)
Table Europe Irritable Bowel Syndrome Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome Treatment Market Share by End User
Figure Asia Pacific Irritable Bowel Syndrome Treatment Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Irritable Bowel Syndrome Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Irritable Bowel Syndrome Treatment Sales by Countries (2014-2019) (MT)
Table Asia Pacific Irritable Bowel Syndrome Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome Treatment Sales Market Share by Countries
Table Asia Pacific Irritable Bowel Syndrome Treatment Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome Treatment Revenue Market Share by Countries
Figure China Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure China Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Japan Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Korea Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure India Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure India Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Australia Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Philippines Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Thailand Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Singapore Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome Treatment Sales by Product (2014-2019) (MT)
Table Asia Pacific Irritable Bowel Syndrome Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome Treatment Market Share by Product
Table Asia Pacific Irritable Bowel Syndrome Treatment Sales by End User (2014-2019) (MT)
Table Asia Pacific Irritable Bowel Syndrome Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome Treatment Market Share by End User
Figure Central & South America Irritable Bowel Syndrome Treatment Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Irritable Bowel Syndrome Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Irritable Bowel Syndrome Treatment Sales by Countries (2014-2019) (MT)
Table Central & South America Irritable Bowel Syndrome Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome Treatment Sales Market Share by Countries
Table Central & South America Irritable Bowel Syndrome Treatment Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome Treatment Revenue Market Share by Countries
Figure Brazil Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Brazil Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Argentina Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Irritable Bowel Syndrome Treatment Sales by Product (2014-2019) (MT)
Table Central & South America Irritable Bowel Syndrome Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome Treatment Market Share by Product
Table Central & South America Irritable Bowel Syndrome Treatment Sales by End User (2014-2019) (MT)
Table Central & South America Irritable Bowel Syndrome Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome Treatment Market Share by End User
Figure Middle East and Africa Irritable Bowel Syndrome Treatment Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Irritable Bowel Syndrome Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome Treatment Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Irritable Bowel Syndrome Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome Treatment Sales Market Share by Countries
Table Middle East and Africa Irritable Bowel Syndrome Treatment Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome Treatment Revenue Market Share by Countries
Figure GCC Countries Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Turkey Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure Egypt Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Irritable Bowel Syndrome Treatment Sales Growth Rate (2014-2019) (MT)
Figure South Africa Irritable Bowel Syndrome Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome Treatment Sales by Product (2014-2019) (MT)
Table Middle East and Africa Irritable Bowel Syndrome Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome Treatment Market Share by Product
Table Middle East and Africa Irritable Bowel Syndrome Treatment Sales by End User (2014-2019) (MT)
Table Middle East and Africa Irritable Bowel Syndrome Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome Treatment Market Share by End User
Table Valeant Pharmaceuticals International Company Details
Table Valeant Pharmaceuticals International Irritable Bowel Syndrome Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Valeant Pharmaceuticals International Recent Development
Table Sucampo Pharmaceuticals Company Details
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Sucampo Pharmaceuticals Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Irritable Bowel Syndrome Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Lexicon Pharmaceuticals Company Details
Table Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Lexicon Pharmaceuticals Recent Development
Table Salix Pharmaceuticals Company Details
Table Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Salix Pharmaceuticals Recent Development
Table Ironwood Pharmaceuticals Company Details
Table Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Ironwood Pharmaceuticals Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Irritable Bowel Syndrome Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Allergan Company Details
Table Allergan Irritable Bowel Syndrome Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table Global Irritable Bowel Syndrome Treatment Sales Forecast by Regions 2019-2025 (MT)
Table Global Irritable Bowel Syndrome Treatment Sales Market Share Forecast by Regions 2019-2025
Table Global Irritable Bowel Syndrome Treatment Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Irritable Bowel Syndrome Treatment Revenue Market Share Forecast by Regions 2019-2025
Table Global Irritable Bowel Syndrome Treatment Sales Forecast by Product 2019-2025 (MT)
Table Global Irritable Bowel Syndrome Treatment Sales Market Share Forecast by Product 2019-2025
Table Global Irritable Bowel Syndrome Treatment Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Irritable Bowel Syndrome Treatment Revenue Market Share Forecast by Product 2019-2025
Table Global Irritable Bowel Syndrome Treatment Sales Forecast by End User 2019-2025 (MT)
Table Global Irritable Bowel Syndrome Treatment Sales Market Share Forecast by End User 2019-2025
Figure North America Irritable Bowel Syndrome Treatment Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Irritable Bowel Syndrome Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Irritable Bowel Syndrome Treatment Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Irritable Bowel Syndrome Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Irritable Bowel Syndrome Treatment Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Irritable Bowel Syndrome Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Irritable Bowel Syndrome Treatment Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Irritable Bowel Syndrome Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Irritable Bowel Syndrome Treatment Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Irritable Bowel Syndrome Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Irritable Bowel Syndrome Treatment Value Chain
Table Irritable Bowel Syndrome Treatment Customers List
Table Irritable Bowel Syndrome Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs